Cargando…

The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution

BACKGROUND AND AIMS: Patients with cirrhosis commonly experience minimal hepatic encephalopathy (MHE), and alterations in neurotransmitters have been thought to be related to cognitive function. However, the relationship between alterations in peripheral and central butyrylcholinesterase (BuChE) wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xuhong, Dang, Pei, Liu, Wenxiao, Ma, Wanlong, Ge, Xin, Zhu, Kai, Wang, Minglei, Huang, Xueying, Ding, Xiangchun, Wang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635509/
https://www.ncbi.nlm.nih.gov/pubmed/36341087
http://dx.doi.org/10.3389/fneur.2022.900997
_version_ 1784824731237613568
author Yang, Xuhong
Dang, Pei
Liu, Wenxiao
Ma, Wanlong
Ge, Xin
Zhu, Kai
Wang, Minglei
Huang, Xueying
Ding, Xiangchun
Wang, Xiaodong
author_facet Yang, Xuhong
Dang, Pei
Liu, Wenxiao
Ma, Wanlong
Ge, Xin
Zhu, Kai
Wang, Minglei
Huang, Xueying
Ding, Xiangchun
Wang, Xiaodong
author_sort Yang, Xuhong
collection PubMed
description BACKGROUND AND AIMS: Patients with cirrhosis commonly experience minimal hepatic encephalopathy (MHE), and alterations in neurotransmitters have been thought to be related to cognitive function. However, the relationship between alterations in peripheral and central butyrylcholinesterase (BuChE) with MHE disease progression remains unknown. As such, this study was designed to investigate potential changes in peripheral and central BuChE activity and their effects on cognitive function in the context of MHE. MATERIALS AND METHODS: We enrolled 43 patients with cirrhosis secondary to hepatitis B, 20 without MHE and 23 with MHE, and 25 with healthy controls (HC). All the selected subjects underwent resting-state functional MRI, and the original images were processed to obtain the regional homogeneity (ReHo) brain maps. Thereafter, the correlation of BuChE activity with ReHo, number connection test of type A (NCT-A), and digital symbol test (DST) scores with MHE patients were analyzed using Person correlation analysis. Meanwhile, we purchased 12 Sprague-Dawley (SD) rats and divided them into an experimental group (n = 6) and a control group (n = 6). The rats in the experimental group were intraperitoneally injected with thioacetamide (TAA) to prepare MHE model rats. After modeling, we used the Morris water maze (MWM) and elevated plus maze (EPM) to assess the cognition function and exploratory behavior of all rats. The activity of serum, hippocampus, and frontal lobe tissue BuChE was detected by ELISA. RESULTS: BuChE activity gradually decreased among the HC, patients with cirrhosis, and MHE groups (all P < 0.01). We observed a linear correlation between serum BuChE and NCT-A and DST scores in MHE patients (all P < 0.01). We noted that BuChE activity can negatively correlate with ReHo values in the left middle temporal gyrus and left inferior temporal gyrus, and positively correlate with ReHo values in the right inferior frontal gyrus, and also found that the peripheral BuChE activity of MHE rats was significantly lower than their control counterparts, and the BuChE activity in frontal lobe extracts was significantly higher than the control rats (all P < 0.05). CONCLUSION: The altered activity of BuChE may contribute to cognitive impairment in MHE patients, which may be a potential biomarker of disease evolution in the context of MHE.
format Online
Article
Text
id pubmed-9635509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96355092022-11-05 The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution Yang, Xuhong Dang, Pei Liu, Wenxiao Ma, Wanlong Ge, Xin Zhu, Kai Wang, Minglei Huang, Xueying Ding, Xiangchun Wang, Xiaodong Front Neurol Neurology BACKGROUND AND AIMS: Patients with cirrhosis commonly experience minimal hepatic encephalopathy (MHE), and alterations in neurotransmitters have been thought to be related to cognitive function. However, the relationship between alterations in peripheral and central butyrylcholinesterase (BuChE) with MHE disease progression remains unknown. As such, this study was designed to investigate potential changes in peripheral and central BuChE activity and their effects on cognitive function in the context of MHE. MATERIALS AND METHODS: We enrolled 43 patients with cirrhosis secondary to hepatitis B, 20 without MHE and 23 with MHE, and 25 with healthy controls (HC). All the selected subjects underwent resting-state functional MRI, and the original images were processed to obtain the regional homogeneity (ReHo) brain maps. Thereafter, the correlation of BuChE activity with ReHo, number connection test of type A (NCT-A), and digital symbol test (DST) scores with MHE patients were analyzed using Person correlation analysis. Meanwhile, we purchased 12 Sprague-Dawley (SD) rats and divided them into an experimental group (n = 6) and a control group (n = 6). The rats in the experimental group were intraperitoneally injected with thioacetamide (TAA) to prepare MHE model rats. After modeling, we used the Morris water maze (MWM) and elevated plus maze (EPM) to assess the cognition function and exploratory behavior of all rats. The activity of serum, hippocampus, and frontal lobe tissue BuChE was detected by ELISA. RESULTS: BuChE activity gradually decreased among the HC, patients with cirrhosis, and MHE groups (all P < 0.01). We observed a linear correlation between serum BuChE and NCT-A and DST scores in MHE patients (all P < 0.01). We noted that BuChE activity can negatively correlate with ReHo values in the left middle temporal gyrus and left inferior temporal gyrus, and positively correlate with ReHo values in the right inferior frontal gyrus, and also found that the peripheral BuChE activity of MHE rats was significantly lower than their control counterparts, and the BuChE activity in frontal lobe extracts was significantly higher than the control rats (all P < 0.05). CONCLUSION: The altered activity of BuChE may contribute to cognitive impairment in MHE patients, which may be a potential biomarker of disease evolution in the context of MHE. Frontiers Media S.A. 2022-10-20 /pmc/articles/PMC9635509/ /pubmed/36341087 http://dx.doi.org/10.3389/fneur.2022.900997 Text en Copyright © 2022 Yang, Dang, Liu, Ma, Ge, Zhu, Wang, Huang, Ding and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Yang, Xuhong
Dang, Pei
Liu, Wenxiao
Ma, Wanlong
Ge, Xin
Zhu, Kai
Wang, Minglei
Huang, Xueying
Ding, Xiangchun
Wang, Xiaodong
The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title_full The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title_fullStr The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title_full_unstemmed The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title_short The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolution
title_sort role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: a potential blood marker of disease evolution
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635509/
https://www.ncbi.nlm.nih.gov/pubmed/36341087
http://dx.doi.org/10.3389/fneur.2022.900997
work_keys_str_mv AT yangxuhong theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT dangpei theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT liuwenxiao theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT mawanlong theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT gexin theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT zhukai theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT wangminglei theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT huangxueying theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT dingxiangchun theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT wangxiaodong theroleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT yangxuhong roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT dangpei roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT liuwenxiao roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT mawanlong roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT gexin roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT zhukai roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT wangminglei roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT huangxueying roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT dingxiangchun roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution
AT wangxiaodong roleofbutyrylcholinesteraseintheregulationofcognitivedysfunctioninminimalhepaticencephalopathyapotentialbloodmarkerofdiseaseevolution